慧安凯

HuiAnKai is a specialized medical technology company based in Beijing, China, focusing on the research, development, and commercialization of interventional vascular devices. The company is best known for its innovative drug-coated balloon (DCB) systems, which are used to treat coronary and peripheral artery diseases by delivering anti-proliferative drugs directly to the vessel wall without the need for a permanent implant. HuiAnKai's product portfolio includes NMPA-approved coronary DCBs and a pipeline of peripheral and neurovascular interventional solutions. By integrating advanced materials science with clinical needs, the company aims to provide stent-free therapeutic options for cardiovascular patients. Their technology leverages a proprietary coating process to ensure optimal drug delivery and vascular healing. The company has received significant backing from prominent venture capital firms, reflecting its leadership in the Chinese interventional cardiology market.